Food Allergy News and Research

First Epinephrine Auto-Injector for Infants and Small Children Will Be Available in 2018

kaléo today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for AUVI-Q® (epinephrine injection, USP) 0.1 mg, the first and only epinephrine auto-injector (EAI) specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 to 33 pounds (7.5 to 15 kilograms) who are at risk for or have a history of serious allergic reactions.

Schools Have Been Able to Treat Anaphylaxis More Than 2,000 Times Thanks to Epinephrine Donation Program

Mylan N.V.(NASDAQ, TASE: MYL) today announced its EpiPen4Schools® program has surpassed the one millionth epinephrine auto-injector donation through the program and that presented data at the American College of Allergy, Asthma and Immunology (ACAAI) 2017 Annual Scientific Meeting demonstrates the impact of and continued need for the program in U.S. schools. Epinephrine auto-injectors provided through the program have been used more than 2,000 times to treat anaphylaxis, a potentially life-threa

New Prevention Guidelines May Reduce Increasing Rates of Peanut Allergy in Children

Parents often worry about peanut allergies because the reaction to peanuts can be very severe. New research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that peanut allergy in children has increased 21 percent since 2010, and that nearly 2.5 percent of U.S. children may have an allergy to peanuts.

Many Pediatricians Are Not Sharing New Peanut Introduction Guidelines With Parents

Guidelines to help parents introduce peanut-containing products to infants to prevent peanut allergies aren’t being discussed. New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows pediatricians are not only not having the discussion, they’re not referring high-risk babies for testing prior to peanut introduction.

Peanut Allergy Patch Study Misses Its Main Goal in Third Phase

Kids With Food Allergies is sharing this press release from DBV Technologies to bring you the latest research news quickly. [Press Release] DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut Allergic Patients Four to 11 Years of Age DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced topline results from the PEPITES (Peanut EPIT Efficacy and Safety) Phase III trial evaluating the safety and efficacy of Viaskin Peanut...

Food Allergy Advocates Work Together to Stop Food Allergy Bullying

Richmond, VA (October 24, 2017) – kaléo, along with the four major advocacy organizations focused on life-threatening allergies, today announced a new initiative, No Appetite for Bullying, to raise awareness about the prevalence and potential dangers of food allergy bullying. Food allergy bullying happens when children and teens living with life-threatening food allergies are teased, ridiculed, or even threatened or assaulted with food to which they are severely allergic. This is the first time

Do Peanut-Free Schools Reduce the Risk of Severe Reactions?

Dr. David Stukus, pediatric asthma and allergy specialist at Nationwide Children’s Hospital and member of the Asthma and Allergy Foundation of America’s Medical Scientific Council, recently wrote an editorial on the findings of the study, Impact of school peanut-free policies on epinephrine administration. This is a summary of his article. Read his full editorial for more information.

Milk Allergy Alert: RI Wang Foods Group Chinese Brand Sausage Products

America New York RI Wang Food Group Recalls Sausage Products Due To Misbranding and an Undeclared Allergen Class I Recall 101-2017 Health Risk: High Sep 15, 2017 En Español Congressional and Public Affairs Felicia Thompson (202) 720-9113 WASHINGTON, Sept. 15, 2017 – America New York RI Wang Food Group, a Maspeth, N.Y. establishment, is recalling approximately 53,973 pounds of Heat Treated but Not Fully Cooked-Not Shelf Stable pork sausage products due to misbranding and...

FDA Acknowledges Study on Early Introduction of Peanut for Allergy Prevention

After conducting a systematic review of the available scientific evidence, the U.S. Food and Drug Administration has determined that it intends to exercise enforcement discretion for the use of a qualified health claim for infants with severe eczema and/or egg allergy characterizing the relationship between the consumption of foods containing ground peanuts beginning between 4 and 10 months of age and a reduced risk of developing peanut allergy by 5 years of age.

Kaléo Donates AUVI-Q® (epinephrine injection, USP) Auto-injectors to Hurricane Harvey Relief Efforts

[Press Release] Kaléo Donates Thousands of AUVI-Q® (epinephrine injection, USP) and EVZIO® (naloxone HCl injection) Auto-injectors to Hurricane Harvey Relief Efforts RICHMOND, Va., Sept. 1, 2017 /PRNewswire/ -- Kaléo, a privately-held pharmaceutical company, today announced a donation of 20,000 AUVI-Q® (epinephrine injection, USP) Auto-injectors and 5,000 EVZIO® (naloxone HCl injection) Auto-injectors to medical aid organization Direct Relief in support of Hurricane Harvey relief efforts in...

Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
4259 W Swamp Rd, Suite 408, Doylestown, PA 18902
Phone: 215.230.5394 | Fax: 215.340.7674